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Evidence has recently been obtained for two different classes of amyloid fibril, one 
consisting of immunoglobulin  light-chain fragments (1), the other having a nonimmu- 
noglobulin protein (protein AS)  as a  major component (2-4). A  serum protein anti- 
genicaUy closely related to protein AS has been found in increased amounts in many 
patients with different types of amyloidosis (5, 6), and may be a  circulating precursor 
of  the fibrils.  1 
We here describe a  third and new class of amyloid subunit, protein AR, derived 
from a patient with primary amyloidosis. This amyloid protein was different from any 
known  amyloid proteins  and  also  from  immunoglobulin fragments.  A  component 
related to amyloid protein AR was detected in the serum of the patient. 
Materials and Methods 
Preparation ofAmyloid Fibrils.--Amyloid  fibrils were isolated from the spleen of the patient 
A. R., a  57 year old male who died only 4--5 mo after the onset of symptoms of generalized 
primary amyloidosis.  There was no evidence for M-components or light-chain disease.  Mter 
removal of soluble proteins, extraction of fibrils was carried out with distilled water  (3, 7). 
For solubilization, the extracted fibrils were treated with 0.1 N NaOH (alkali-degraded amy- 
loid), or with 6 M guanidine/0.1 M dithiothreitol (DTT) (3). Amyloid preparations from pa- 
tients with primary (J.  R.)  (4) or secondary amyloidosis (T. H.)  (3, 4, 8), and from two pa- 
tients with amyloidosis associated with WaldenstrSm's macroglobulirmemia (J. B. and E. F.) 
(4, 6), were  also included for comparison. All the crude amyloid fibril preparations used in 
the immunologic experiments were degraded with 0.1 N  NaOH. 
Sera and Serum Proteins.--Since regular serum from the  patient A. R.  was  not availa- 
ble,  blood  squeezed  from  the  vessels  of  the fiver was  used.  60  sera  from  patients with 
different clinical types of amyloidosis were tested in addition to pooled and individual  normal 
sera, and isolated serum proteins and fragments (4). 
Antisera.--Antiamyloid antisera were obtained by immunizing  rabbits with alkali-degraded 
amyloid fibrils. Antisera to human serum and various serum proteins were also used (3, 4). 
Gel Filtration.--For the isolation of subfragments, amyloid fibrils treated with NaOH or 
with guanidine/DTT were gel filtered on Sephadex  G-100 columns (Pharmacia Fine Chemi- 
cals, Inc., Uppsala, Sweden) equilibrated with 5 M  guanidine--1 N  acetic acid, followed by 
gel filtration on Sephadex  G-25 medium equilibrated with 10% formic acid (3). 
RESULTS 
Antigenic Properties  of Amyloid A.R. and Its Subfragments.--When  amyloid 
A. R.  was  reacted  with  an  antiserum to  secondary  amyloid T.  H.,  only one 
*Supported by the Norwegian Medical Research Council. 
1 Husby, G., and J. B. Natvig. 1974. A serum component related to nonimmunoglobulin 
amyloid protein AS, a possible precursor of the fibrils. Y. Clin. Invest. In press. 
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precipitation line fusing with that of the high molecular weight component of 
amyloid T.  H.  (void volume material at  Sephadex  G-100 [3]) was observed 
(Fig.  1 A). No reaction was obtained with two strong antisera to protein AS 
(antiamyloid J. B. and antiamyloid T. H.) (Fig. 1 A). However, when amyloid 
A. R. was reacted with antiamyloid A. R,, a distinct precipitation line was ob- 
tained (Fig. 1 C). No other amyloid preparation or their subfragments studied, 
altogether 21  amyloid preparations (4), gave any precipitation line with anti- 
amyloid A. R.,  and did not even inhibit the precipitation reaction between 
amyloid A. R. and antiamyloid A. R. (Fig. 1 C). 
These findings strongly indicate that amyloid A. R. lacked the nonimmuno- 
globulin protein AS which has been found in nearly all amyloid preparations 
studied.  In  addition,  amyloid A.  R.  appeared  to  contain antigenic material 
different from all the other  amyloid preparations.  When antiamyloid A.  R. 
was  tested  against  normal  human  serum,  immunoglobulins  and  fragments 
thereof, and a panel of monoclonal IgG, IgA, and IgM proteins, and 12 differ- 
ent  Bence-Jones proteins,  no  precipitation  line was  obtained.  Furthermore, 
no precipitation reaction was obtained between amyloid A. R. and antisera to 
IgG, IgA, IgM, F(abr)2,  light chains, and whole human serum. Immunoelec- 
trophoresis  revealed  an  electrophoretic  mobility of  amyloid A.  R.  slightly 
anodic to the application point (Fig. 1 D). 
Gel filtration of degraded amyloid A. R. yielded two main components (Fig. 
2).  One subfragment (protein AR)  was eluted corresponding to a  mol wt of 
approximately 16,000 daitons with a yield of 66% of the total protein eluted. 
The other main component (25 %),  the void volume material, had a  mol wt 
higher than 70,000. No protein AS was eluted even when NaOH was used for 
degradation of amyloid A. R. before gel filtration. 
Double immunodiffusion of antiamyloid A. R. against the subfragments of 
amyloid A. R. showed that material from the protein peak with mol wt 16,000 
daltons (protein AR) gave a precipitation line fusing with that obtained with 
crude amyloid A. R. The component of amyloid A. R. eluted in the void vol- 
ume was, however, not precipitated (Fig.  1 C). However, antiamyloid T. H. 
reacted with the void volume material of amyloid A. R., giving a precipitation 
line of identity with that of the void volume material of amyloid T. H. (Fig. 1 A). 
Amyloid E.  F.  also  appeared to be different from preparations previously 
studied. Amyloid E. F. was precipitated by antiamyloid T. H., giving a  line 
of identity with that of the void volume components of amyloid T. H. and A. R. 
In contrast, no precipitation reaction related to protein AS or protein AR was 
obtained with amyloid E.  F.  (Table I). However, both crude amyloid E.  F. 
and  a  20,000  daltons subfragment constituting 67 %  of the  total protein of 
amyloid E.  F. were precipitated by an antiserum to X-light  chains, giving a 
reaction of partly identity with three different X-Bence-Jones  proteins  (Table 
I). No reaction was seen with anti-K-light chains. 
Protein  AR-Related  Component in  Serum.--Antiamyloid  A.  R.  was  also HUSB¥~  NATVIG~ SLETTEN  BRIEF  DEFINITIVE REPORT  775 
FIG. 1.  (.4) Antiamyloid T. H. in central well tested against amyloid T. H. (well 1); amyloid 
A.  R.  (2);  the  high  molecular weight  subfragment  (the  void volume materiai--Sephadex 
G-100)  of amyloid A. R. (3) protein AR subfragment of amyloid A. R. (4); and saline (5, 6). 
The precipitation line of amyloid T. H. (1) closer to the antiserum well is due to protein AS, 
while the other precipitation line fusing with that  of amyloid A. R.  (2)  corresponds to the 
void volume material of amyloid T. H. (B) Antiamyloid A. R. in central well tested  against 
amyloid A. R.  (well 1); serum of patient A. R.  (2); protein AR subfragment of amyloid A. 
R.  (3); normal serum (5);  and saline.  (4,  6).  (C)  Antiamyloid A.  R.  in central  well tested 
against amyloid  A. R.  (wells  1,  4); amyloid T.  H.  (2)  protein  AS of amyloid T.  H.  (3); 
amyloid J. B. (5); and  the void volume material of amyloid A. R.  (6).  (D)  Immtmoelectro- 
phoresis of amyloid A. R.  (upper well)  and  normal serum  (lower  well). Antiamyloid  A.  R. 
in upper  throw and anti-whole serum in lower throw. Anode to the left. 776  HUSBY,  NATVIG~ SLETTEN  BRIEF DEFINITIVE  REPORT 
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Fzo. 2.  Gel filtration of amyloid A. R. on a 3.2  X  96.5-cm Sephadex  G-100 column with 
V0 =  240 ml. Elution rate 8.1 ml/h. Fraction volume: 5.42 ml. Elution buffer: 5 M guanidine 
1 ~m  in 1 N  acetic acid (Temperature 23°). Sample volume 13.5 ml. OD,s0 nm= 20. The yield of 
material with Kay 0.39 (protein AR) was 66%, determined by estimation of the areas of the 
peaks. 
TABLE I 
Antigenicity of Various Amyloid Subfragments from Different Types of Amyloid Fibril 
Amyloid  E.B.  Vo ma-  Protein  Light  chains  Protein  and its sub- 
Patient  terial  AS  K  k  AR  fragments* 
A.R.  Primary amyloidosis:~  +  --  --  --  +  -- 
J.R.  Primary amyloidosis§ 
T.H.  Secondary amyloidosis§  +  +  --  --  --  -- 
J.B.  WaldenstrSm's 
macroglobulinaemia  § 
E.F.  Waldenstriim's  +  --  --  +  --  -- 
macroglobulinaemia[] 
E.B.  Myelomatosis, amyloid  .....  + 
tumour* 
* Amyloid E. B., kindly  provided by Dr. E. F. Osserman, has previously been shown to be 
antigenically unique (3, 4). 
Amyloid material kindly provided by Dr. F. Sauger. 
§ Previously studied in (3, 4). These three preparations showed the same pattern as indi- 
cated for T. H. 
[] Amyloid material kindly provided by Dr. E. C. Franklin. 
tested against pooled and single normal sera and 60 sera containing the protein 
AS-related  component.  No  precipitation  reaction  was  obtained  with  any  of 
these sera. However,  the serum from the patient A. R. showed a  precipitation 
reaction of identity with crude amyloid A. R. as well as with its subunit protein 
AR  (Fig.  1  B).  The  protein AS-related  component could not be detected  in 
this serum. 
Additional Studies to Identify Amyloid Subunit Protein AR.--Partial N-ter- 
minal amino acid sequence analysis by Edman  degradation  (3)  of the protein 
AR subfragment of amyloid A.  R.  yielded only one amino acid in each  step, 
indicating that this component was a  homogenous protein. The  11  N-terminal 
amino  acids  were  Asp-Phe-Met-Leu-Thr-Gln-Pro-His-Val-Ser-Glu. This  se- 
quence is completely different from the corresponding amino acids of the non- HUSBY,  NATVIG,  SLETTEN  BRIEF  DEFINITIVE  REPORT  777 
immunoglobulin amyloid protein AS  (8),  and  cannot  be  identified with  any 
known N-terminal  sequences  of  light-chain variable subgroups or  with  any 
known sequence in another part of immunoglobulin chains  2 (9, 10).  The most 
remarkable characteristics of the amino acid composition of protein AR  ~ were 
the high content of proline (7.74%)  and the low content of the basic amino 
acids lysine (3.59%) and arginine (2.70%) 
DISCUSSION 
The subfragment comprising 66 %  of the proteins of amyloid fibrils A. R. 
was different from any known amyloid protein. Amyloid A. R. lacked the non- 
immunoglobulin protein AS, but consisted instead of another completely differ- 
ent subunit, which we have called protein AR. Strongly reacting antisera to 
this protein AR did not precipitate with any other amyloid preparations or 
subfragments thereof, or with immunoglobulins or their chains and fragments. 
The immunologic studies thus showed the presence of a new, uncommon arnyloid 
fibril protein. 
This was further supported by the chemical data. Although some amino acid 
residues in the N-terminal part of the polypeptide chains were somewhat simi- 
lar to K-light chains, other residues were completely different from both known 
light chain and protein AS sequences (8-10). 
Furthermore,  the  serum  from the patient A. R. contained a  protein anti- 
genically related to the amyloid protein AR. This protein could not be detected 
in any of our other sera from patients with amyloidosis, but has recently been 
found in a  few cases within a  larger panel of sera from patients prone to get 
amyloidosis.* On the other hand, serum from the patient A. R. did not contain 
the protein AS-related component which was present in most of the other cases 
of amyloidosis tested (6, footnote 1). We therefore, suggest that protein AR is 
a major component of a third class of amyloid fibril. Despite the fact that pro- 
tein AR was not detected in any other amyloid preparation, the void volume 
material of amyloid A. R. was antigenically similar to that of nearly all amy- 
loid preparations studied. The most pronounced antigenic differences among 
the various amyloids studied therefore  appear  to  be  related  to  the  smaller 
subfragments.  Many amyloid preparations  (e.g.,  arnyloid T.  H.,  J.  R.,  and 
J. B.)  contained protein AS, while amyloid A. R. contained protein AR with 
apparently unique anfigenicity. Amyloid E. F. seemed to be a representative 
of fibrils closely related to light-chain fragments (1).  This indicates that differ- 
ent proteins can, perhaps in interaction with the void volume material, form 
highly insoluble fibrils with similar ultrastructural and optical features. Fur- 
ther studies will probably yield a larger number of amyloid-forming proteins. 
2 Capra, D. 1973, personal communication. 
3 Husby, G., J. B. Natvig, and K. Sletten, unpublished  observations. 
4 Husby, G., J. B. Natvig, and M. Harboe. 1974. Scaml. J. Immunol. In press. 778  HUSB¥~ NATVIG, SLETTEN  BRIEF  DEFINITIVE REPORT 
SUMMARY 
An  unusual  protein  AR  was  isolated  from  the  amyloid fibril  preparation 
derived from a patient with primary amyloidosis. Protein AR was unique  in 
its antigenicity,  and revealed no structural identity with any known amyloid 
proteins or with immunoglobulin chains or fragments. Thus  a  new  third  class 
of  amyloid  fibril  proteins  besides  the  immunogiobulin  light-chain  variable 
region fragments and the nonimmunoglobulin protein AS, has been character- 
ized. A component antigenically related to protein AR was found in the serum 
of the patient. 
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